INTC

Intel Corporation

65
Fundamentals73/ 100
Valuation50/ 100
Upside potential64/ 100
Risk potential42/ 100

INTC lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.

MASK

3 E Network Technology Group Ltd Class A Ordinary Shares

There isn't enough reported data to score MASK yet.

INTC Fundamentals

MetricStatus
Healthy
Under pressure
Healthy
Healthy

INTC's revenue, cash flow and balance sheet are currently healthy, but its profitability is under pressure.

MASK Fundamentals

MetricStatus
Unavailable
Healthy
Unavailable
Strong

MASK's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.

INTC PE Valuation

INTC has no meaningful PE right now: it lost money over the past year.

MASK PE Valuation

MASK has no meaningful PE right now: it lost money over the past year.

INTC Forward outlook

MetricOutlook
--
Strong growth
Growth
Strongly improving
Broad
Low

Analysts expect earnings and revenue growth for INTC, with profitability improving. However, they disagree widely on these estimates.

MASK Forward outlook

There aren't enough analyst estimates for MASK to show an outlook.

INTC Risk to reward

ScenarioChangePrice
Upside+76%$107.41
Downside-42%$35.74

Calculated from the latest close: $61.20 on Nov 12.

There is not enough scenario data to compare INTC and MASK's risk to reward.

MASK Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $1.85 on Nov 12.

There is not enough scenario data to compare INTC and MASK's risk to reward.

INTC Earnings Per Share

Q4 2023: $0.40Q1 2024: $0.97Q2 2024: $0.24Q3 2024: $-3.71Q4 2024: $-4.38Q1 2025: $-4.48Q2 2025: $-4.77Q3 2025: $0.01Q4 2025: $-0.06Q1 2026: $-0.60Q2 2026: $-2.09Q3 2026: $-2.39Forward: $1.41
Q4 2023: $0.40Q1 2024: $0.97Q2 2024: $0.24Q3 2024: $-3.71Q4 2024: $-4.38Q1 2025: $-4.48Q2 2025: $-4.77Q3 2025: $0.01Q4 2025: $-0.06Q1 2026: $-0.60Q2 2026: $-2.09Q3 2026: $-2.39Forward: $1.41
QuarterTTM EPSYoY
Forward$1.41—
Q3 2026-$2.39-24000%
Q2 2026-$2.09+$2.68
Q1 2026-$0.60+$3.88
Q4 2025-$0.06+$4.32
Q3 2025$0.01+$3.72
Q2 2025-$4.77-2088%
Q1 2025-$4.48-562%
Q4 2024-$4.38-1195%

INTC has swung to a loss: it lost $2.39 per share over the past year, after a profit the year before.

MASK Earnings Per Share

Q3 2024: $23.43Q4 2024: $26.85
Q3 2024: $23.43Q4 2024: $26.85

MASK and INTC do not have enough comparable growth data to identify a winner.

INTC Quarterly Revenue

Q4 2023: $15.4BQ1 2024: $12.7BQ2 2024: $12.8BQ3 2024: $13.3BQ4 2024: $14.3BQ1 2025: $12.7BQ2 2025: $12.9BQ3 2025: $13.7BQ4 2025: $13.7BQ1 2026: $13.6BQ2 2026: $16.1BQ3 2026: $16.5B
Q4 2023: $15.4BQ1 2024: $12.7BQ2 2024: $12.8BQ3 2024: $13.3BQ4 2024: $14.3BQ1 2025: $12.7BQ2 2025: $12.9BQ3 2025: $13.7BQ4 2025: $13.7BQ1 2026: $13.6BQ2 2026: $16.1BQ3 2026: $16.5B
QuarterRevenueYoY
Q3 2026$16.5B+21%
Q2 2026$16.1B+25%
Q1 2026$13.6B+7.2%
Q4 2025$13.7B-4.1%
Q3 2025$13.7B+2.8%
Q2 2025$12.9B+0.2%
Q1 2025$12.7B-0.4%
Q4 2024$14.3B-7.4%

INTC's revenue is recovering but still below its 2021 peak: $16.5B last quarter, up 21% from the same quarter a year ago.

MASK Quarterly Revenue

Q4 2022: $270,478Q2 2023: $1MQ4 2023: $3MQ1 2024: $794,926Q2 2024: $2MQ3 2024: $2MQ4 2024: $3MQ2 2025: $2MQ2 2026: $7M
Q4 2022: $270,478Q2 2023: $1MQ4 2023: $3MQ1 2024: $794,926Q2 2024: $2MQ3 2024: $2MQ4 2024: $3MQ2 2025: $2MQ2 2026: $7M
QuarterRevenueYoY
Q2 2026$7.2M+321%
Q2 2025$1.7M+7.4%
Q4 2024$3.1M+5.3%
Q2 2024$1.6M+13%
Q4 2023$3M+999%

MASK has the edge over INTC in the latest year-over-year revenue comparison.

INTC Free Cash Flow

Q4 2023: −$2.1BQ1 2024: −$7.2BQ2 2024: −$3.4BQ3 2024: −$2.4BQ4 2024: −$2.7BQ1 2025: −$4.4BQ2 2025: −$1.5BQ3 2025: $121MQ4 2025: $800MQ1 2026: −$2.5BQ2 2026: $4.5BQ3 2026: $1.1B
Q4 2023: −$2.1BQ1 2024: −$7.2BQ2 2024: −$3.4BQ3 2024: −$2.4BQ4 2024: −$2.7BQ1 2025: −$4.4BQ2 2025: −$1.5BQ3 2025: $121MQ4 2025: $800MQ1 2026: −$2.5BQ2 2026: $4.5BQ3 2026: $1.1B
QuarterFree cash flowYoY
Q3 2026$1.1B+774%
Q2 2026$4.5B+$6B
Q1 2026-$2.5B+$1.8B
Q4 2025$800M+$3.5B
Q3 2025$121M+$2.5B
Q2 2025-$1.5B+$1.9B
Q1 2025-$4.4B+$2.8B
Q4 2024-$2.7B-$597M

INTC has the edge over MASK in the latest year-over-year cash flow comparison.

MASK Free Cash Flow

Q4 2022: $365,230Q2 2023: $524,570Q4 2023: $204,500Q1 2024: $362,353Q2 2024: $724,700Q3 2024: $194,725Q4 2024: $389,450Q2 2025: --Q2 2026: −$3M
Q4 2022: $365,230Q2 2023: $524,570Q4 2023: $204,500Q1 2024: $362,353Q2 2024: $724,700Q3 2024: $194,725Q4 2024: $389,450Q2 2025: --Q2 2026: −$3M
QuarterFree cash flowYoY
Q4 2024$389.5K+90%
Q2 2024$724.7K+38%
Q4 2023$204.5K-44%

MASK's free cash flow has turned negative after years in the green: −$2M over the past year.

INTC Total Shares

Q4 2023: 4.2BQ1 2024: 4.2BQ2 2024: 4.3BQ3 2024: 4.3BQ4 2024: 4.3BQ1 2025: 4.3BQ2 2025: 4.4BQ3 2025: 4.5BQ4 2025: 4.5BQ1 2026: 5.1BQ2 2026: 5.1BQ3 2026: 5.3B
Q4 2023: 4.2BQ1 2024: 4.2BQ2 2024: 4.3BQ3 2024: 4.3BQ4 2024: 4.3BQ1 2025: 4.3BQ2 2025: 4.4BQ3 2025: 4.5BQ4 2025: 4.5BQ1 2026: 5.1BQ2 2026: 5.1BQ3 2026: 5.3B
PeriodChange %Net change
Quarterly+4%+203M shares
1 year+17%+776M shares
3 years+25%+1.1B shares
5 years+30%+1.2B shares
Available history+19%+834M shares

INTC has 5.3B diluted shares, up 17% from a year ago.

MASK Total Shares

Q4 2022: 112,500Q2 2023: 112,500Q4 2023: 112,500Q1 2024: 100,000Q2 2024: 112,500Q3 2024: 100,000Q4 2024: 112,500
Q4 2022: 112,500Q2 2023: 112,500Q4 2023: 112,500Q1 2024: 100,000Q2 2024: 112,500Q3 2024: 100,000Q4 2024: 112,500
PeriodChange %Net change
Quarterly+13%+12.5K shares
1 year0%--

MASK has the edge over INTC on shareholder dilution, with a more favorable share count trend.

INTC Net Leverage

Q4 2023: 4.4xQ1 2024: 4.4xQ2 2024: 4.3xQ3 2024: 23.8xQ1 2025: 69.6xQ3 2025: 4.0xQ4 2025: 3.4xQ1 2026: 3.9xQ2 2026: 3.1xQ3 2026: 2.0x
Q4 2023: 4.4xQ1 2024: 4.4xQ2 2024: 4.3xQ3 2024: 23.8xQ1 2025: 69.6xQ3 2025: 4.0xQ4 2025: 3.4xQ1 2026: 3.9xQ2 2026: 3.1xQ3 2026: 2.0x
QuarterNet LeverageStatus
Q3 20262.0xHealthy
Q2 20263.1xElevated
Q1 20263.9xElevated
Q4 20253.4xElevated
Q3 20254.0xElevated
Q1 202569.6xHigh
Q3 202423.8xHigh
Q2 20244.3xHigh

INTC's net debt is about 2.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.

MASK Net Leverage

Q3 2024: 0.0xQ4 2024: 0.0x
Q3 2024: 0.0xQ4 2024: 0.0x
QuarterNet LeverageStatus
Q4 20240.0xVery low
Q3 20240.0xVery low

MASK's net debt is less than a year of its operating earnings (EBITDA).

INTC Weekly Momentum

MetricValueStatus
RSI38.1Neutral
Stochastic7.7Oversold

INTC's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).

MASK Weekly Momentum

As of the close on Nov 12, 2026: $1.85.

INTC PE vs Technology Sector

MetricINTCSector medianRelative
PEN/A28x—

INTC has no meaningful PE right now: it lost money over the past year.

MASK PE vs Technology Sector

MASK has no meaningful PE right now: it lost money over the past year.

INTC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$88.431% below
20 week MA$95.336% below
50 week MA$79.323% below
100 week MA$52.118% above
200 week MA$42.544% above

INTC has stronger trend alignment. INTC is above 2 of 5 weekly averages versus MASK above 0 of 1.

MASK Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$2.8736% below

MASK is in a downtrend: it's below all one of its weekly moving averages, and 36% below its 8-week average.

INTC Yearly ROI

YearStart priceEnd priceROI
2020$60.1$47.1-22%
2021$47.1$51.3+9%
2022$51.3$26.1-49%
2023$26.1$50.3+93%
2024$50.3$20.3-60%
2025$20.3$36.2+78%
2026 YTD$36.2$61.2+69%

INTC has the edge over MASK on returns for 2026, with the stronger performance.

MASK Yearly ROI

YearStart priceEnd priceROI
2026 YTD$4.92$1.85-62%

It's down 62% so far in 2026.

Give your agent the market.

Get API key